340B program continues to drive shift in care to more expensive hospital settings
PhRMA
DECEMBER 15, 2022
In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.
Let's personalize your content